Skip to main content

Vanderbilt Ingram Cancer Center Archives

Lung cancer survival signal

Nov. 30, 2018—New research by Jonathan Lehman and Pierre Massion have identfied a bioimarker that suggests poor prognosis for small-cell lung cancer, as well as potential target for new therapies.

Read more


Grant enhances study of new chemotherapy targets

Oct. 19, 2018—Vanderbilt chemists have been awarded $7.2 million over the next five years from the National Cancer Institute to lead an initiative to better understand how a combination chemotherapy for breast cancer targets DNA.

Read more


Study tracks incidence, timing of immunotherapy-related deaths

Sep. 13, 2018—Researchers led by melanoma researcher Douglas Johnson have answered questions about the incidence and timing of rare but sometimes fatal reactions to the most widely prescribed class of immunotherapies.

Read more


My Southern Health: The symptoms of cholangiocarcinoma

Jul. 13, 2018—The signs of this rare bile-duct cancer typically go unnoticed at first. Here’s what to know.

Read more


Lung cancer patients and advocates visit VUMC research labs

Jun. 14, 2018—A group of young lung cancer patients and their family members recently toured research laboratories at Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center (VICC) to learn how investigators are working to find better therapies and possibly a cure for the disease.

Read more


Jagasia to succeed Neuss as VICC Chief Medical Officer

Jun. 12, 2018—After successfully leading Vanderbilt-Ingram Cancer Center (VICC) through years of growth in patient volumes and enhanced care options, Michael Neuss, MD, Chief Medical Officer of the VICC Clinical Enterprise, is retiring as CMO. Neuss will be succeeded by Madan Jagasia, MBBS, MSCI, MMHC, who has been named to the George and Beverley Rawlings Directorship and is section chief, Hematology and Stem Cell Transplant and director of the Outpatient Stem Cell Clinic.

Read more


VUMC and VICC lauded by CEO Roundtable on Cancer for employee support

May. 31, 2018—For the 10th year in a row Vanderbilt University Medical Center (VUMC) and Vanderbilt-Ingram Cancer Center (VICC) have been named a CEO Cancer Gold Standard employer by the

Read more


Berlin assumes new VICC leadership post

May. 29, 2018—Jordan Berlin, MD, has been named associate director of Clinical Investigation Strategy and Shared Resources at Vanderbilt-Ingram Cancer Center (VICC).

Read more


New method to thwart false positives in CT-lung cancer screening

May. 24, 2018—A team of investigators led by Fabien Maldonado, MD, associate professor of Medicine at Vanderbilt, and Tobias Peikert, MD, assistant professor of Medicine at Mayo Clinic, Rochester, Minnesota, has identified a new technology to address false positives in CT-based lung cancer screening. The study was published in the latest issue of PLOS One.

Read more


Park named to VICC breast cancer leadership position

May. 17, 2018—  Internationally renowned breast cancer expert Ben Ho Park, MD, PhD, has been named co-leader of the Breast Cancer Research Program, director of Precision Oncology and associate director for Translational Research at Vanderbilt-Ingram Cancer Center. In his academic role, he will serve as professor of Medicine. Park, who will assume his new post Sept. 1,...

Read more


Grant bolsters kidney cancer immunotherapy research

May. 10, 2018—W. Kimryn Rathmell, MD, PhD, Cornelius Abernathy Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt-Ingram Cancer Center (VICC), has received a grant to research the role of immunosuppression in the tumor microenvironment for kidney cancer.

Read more


VICC Scientific Retreat shines light on microbiome

May. 10, 2018—Two Vanderbilt students were honored for their stellar scientific research during the Vanderbilt-Ingram Cancer Center (VICC) Annual Scientific Retreat held May 3 at the Vanderbilt University Student Life Center.

Read more


Upcoming Events

MORE EVENTS »